Siemens Healthineers AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE000SHL1006
EUR
35.76
-10.85 (-23.28%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

977.58 k

Shareholding (Dec 2025)

FII

0.01%

Held by 2 FIIs

DII

99.99%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

High Debt Company with a Debt to Equity ratio (avg) at times

  • Poor long term growth as Operating profit has grown by an annual rate 12.09% of over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at times
2

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 40,337 Million ()

stock-summary
P/E

19.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.80%

stock-summary
Debt Equity

0.81

stock-summary
Return on Equity

12.73%

stock-summary
Price to Book

2.19

Revenue and Profits:
Net Sales:
5,402 Million
(Quarterly Results - Dec 2025)
Net Profit:
456 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-31.15%
0%
-31.15%
6 Months
-33.18%
0%
-33.18%
1 Year
-34.74%
0%
-34.74%
2 Years
-31.68%
0%
-31.68%
3 Years
-32.12%
0%
-32.12%
4 Years
-24.84%
0%
-24.84%
5 Years
-16.84%
0%
-16.84%

Siemens Healthineers AG for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
9.58%
EBIT Growth (5y)
8.50%
EBIT to Interest (avg)
18.12
Debt to EBITDA (avg)
2.96
Net Debt to Equity (avg)
0.75
Sales to Capital Employed (avg)
0.62
Tax Ratio
24.22%
Dividend Payout Ratio
52.23%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
9.64%
ROE (avg)
11.15%

Valuation key factors

Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
2.37
EV to EBIT
16.27
EV to EBITDA
11.83
EV to Capital Employed
1.83
EV to Sales
2.39
PEG Ratio
NA
Dividend Yield
2.58%
ROCE (Latest)
11.26%
ROE (Latest)
12.73%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 2 Foreign Institutions (0.01%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -1.46% vs 5.91% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -4.60% vs 10.65% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "5,402.00",
          "val2": "5,482.00",
          "chgp": "-1.46%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,022.00",
          "val2": "1,036.00",
          "chgp": "-1.35%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "96.00",
          "val2": "108.00",
          "chgp": "-11.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-49.00",
          "val2": "-33.00",
          "chgp": "-48.48%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "456.00",
          "val2": "478.00",
          "chgp": "-4.60%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "134.00%",
          "val2": "133.30%",
          "chgp": "0.07%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Sep 2025 is 4.53% vs 3.15% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Sep 2025 is 10.67% vs 28.46% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "23,375.00",
          "val2": "22,363.00",
          "chgp": "4.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4,731.00",
          "val2": "4,523.00",
          "chgp": "4.60%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "425.00",
          "val2": "476.00",
          "chgp": "-10.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-250.00",
          "val2": "-431.00",
          "chgp": "42.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "2,168.00",
          "val2": "1,959.00",
          "chgp": "10.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "147.00%",
          "val2": "147.60%",
          "chgp": "-0.06%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoYstock-summary

Dec'25
Dec'24
Change(%)
Net Sales
5,402.00
5,482.00
-1.46%
Operating Profit (PBDIT) excl Other Income
1,022.00
1,036.00
-1.35%
Interest
96.00
108.00
-11.11%
Exceptional Items
-49.00
-33.00
-48.48%
Consolidate Net Profit
456.00
478.00
-4.60%
Operating Profit Margin (Excl OI)
134.00%
133.30%
0.07%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2025 is -1.46% vs 5.91% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is -4.60% vs 10.65% in Dec 2024

Annual Results Snapshot (Consolidated) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
23,375.00
22,363.00
4.53%
Operating Profit (PBDIT) excl Other Income
4,731.00
4,523.00
4.60%
Interest
425.00
476.00
-10.71%
Exceptional Items
-250.00
-431.00
42.00%
Consolidate Net Profit
2,168.00
1,959.00
10.67%
Operating Profit Margin (Excl OI)
147.00%
147.60%
-0.06%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Sep 2025 is 4.53% vs 3.15% in Sep 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Sep 2025 is 10.67% vs 28.46% in Sep 2024

stock-summaryCompany CV
About Siemens Healthineers AG stock-summary
stock-summary
Siemens Healthineers AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available